Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Arcutis, Inc. (to 9/9/2019)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 521 % -42.7%
Quick Ratio 17.1 % -35.2%
Debt-to-equity 159 % -21.5%
Return On Equity -119 % +47%
Return On Assets -46 % +38.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 117M shares +24%
Common Stock, Shares, Outstanding 117M shares +89.1%
Entity Public Float 487M USD -44.6%
Common Stock, Value, Issued 12K USD +100%
Weighted Average Number of Shares Outstanding, Basic 124M shares +101%
Weighted Average Number of Shares Outstanding, Diluted 124M shares +101%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 44.8M USD +17.4%
Research and Development Expense 85.7M USD -29%
General and Administrative Expense 84.8M USD +123%
Costs and Expenses 321M USD +11.7%
Operating Income (Loss) -182M USD +26.7%
Nonoperating Income (Expense) -14.6M USD -354%
Income Tax Expense (Benefit) 414K USD -100%
Net Income (Loss) Attributable to Parent -196M USD +27%
Earnings Per Share, Basic -1.65 USD/shares +62.4%
Earnings Per Share, Diluted -1.65 USD/shares +62.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 135M USD +25.5%
Accounts Receivable, after Allowance for Credit Loss, Current 60.1M USD +210%
Inventory, Net 14M USD +0.73%
Assets, Current 424M USD +50.5%
Property, Plant and Equipment, Net 1.19M USD -31.6%
Operating Lease, Right-of-Use Asset 2.06M USD -16.1%
Intangible Assets, Net (Excluding Goodwill) 9.79M USD +47.8%
Other Assets, Noncurrent 596K USD 0%
Assets 437M USD +49.3%
Accounts Payable, Current 19.3M USD +46.6%
Employee-related Liabilities, Current 15.6M USD +13.8%
Accrued Liabilities, Current 52.8M USD +88.6%
Liabilities, Current 172M USD +312%
Operating Lease, Liability, Noncurrent 2.77M USD -22.4%
Other Liabilities, Noncurrent 420K USD
Liabilities 281M USD +14%
Accumulated Other Comprehensive Income (Loss), Net of Tax 533K USD
Retained Earnings (Accumulated Deficit) -1.11B USD -21.4%
Stockholders' Equity Attributable to Parent 157M USD +235%
Liabilities and Equity 437M USD +49.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +60.7%
Net Cash Provided by (Used in) Financing Activities 162M USD
Net Cash Provided by (Used in) Investing Activities -28.7M USD -127%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 117M shares +89.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 101M USD +269%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 135M USD +25%
Deferred Tax Assets, Valuation Allowance 216M USD +32.8%
Deferred Tax Assets, Gross 217M USD +32.5%
Operating Lease, Liability 4.12M USD -13.8%
Depreciation 766K USD +18.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -195M USD +26.9%
Lessee, Operating Lease, Liability, to be Paid 4.81M USD -16.7%
Property, Plant and Equipment, Gross 3.46M USD +14.1%
Operating Lease, Liability, Current 798K USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD +3.02%
Lessee, Operating Lease, Liability, to be Paid, Year One 994K USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 695K USD -30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD +2.93%
Deferred Tax Assets, Operating Loss Carryforwards 152M USD +44.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 41.4M USD -2.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD +3.13%
Operating Lease, Payments 241K USD +36.9%
Additional Paid in Capital 1.27B USD +31.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 750K USD 0%
Share-based Payment Arrangement, Expense 41.6M USD +5.67%
Interest Expense 30.2M USD +44.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%